Data as of Jan 28
| -0.93 / -1.54%|
The 5 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 62.00, with a high estimate of 80.00 and a low estimate of 58.00. The median estimate represents a +4.43% increase from the last price of 59.37.
The current consensus among 6 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.